EDGAR Filing Documents for 0001193125-20-218261

Form 8-K - Current report:

SEC Accession No. 0001193125-20-218261

Filing Date

2020-08-13

Accepted

2020-08-13 06:33:58

Documents

Period of Report

2020-08-11

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d83080d8k.htm	8-K	18812
2	EX-99.1	d83080dex991.htm	EX-99.1	8250
3	GRAPHIC	g83080g81y70.jpg	GRAPHIC	5062
	Complete submission text file	0001193125-20-218261.txt		35370

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110

Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244

Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 201097127
SIC: 2834 Pharmaceutical Preparations